Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled study.
Saved in:
| Title: | Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled study. |
|---|---|
| Authors: | Hamer MJ; Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA; Department of Emergency Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC, USA., McCarty JM; Stanford University School of Medicine, Stanford, CA, USA., Pierson BC; Division of Medicine, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA., Regules JA; Division of Medicine, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA; Uniformed Services University (USU) F Edward Hebert School of Medicine, Bethesda, MD, USA., Mendy J; Bavarian Nordic, San Diego, CA, USA., Sanborn AD; Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA., Gardner CL; Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA., Haller JM; Division of Medicine, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA., Gregory MK; Division of Medicine, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA., Liggett DL; Division of Medicine, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA., Glass PJ; Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA., Ghosh N; Emergent BioSolutions, Gaithersburg, MD, USA., Royalty Tredo S; Emergent BioSolutions, Gaithersburg, MD, USA., Warfield KL; Emergent BioSolutions, Gaithersburg, MD, USA., Burke CW; Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA., Lee C; Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA., Saunders D; Division of Medicine, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA; Uniformed Services University (USU) F Edward Hebert School of Medicine, Bethesda, MD, USA., Bedell L; Bavarian Nordic, San Diego, CA, USA., Richardson JS; Bavarian Nordic Canada, Toronto, ON, Canada. Electronic address: JARI@bavarian-nordic.com. |
| Source: | The Lancet. Microbe [Lancet Microbe] 2025 Apr; Vol. 6 (4), pp. 101000. Date of Electronic Publication: 2025 Feb 12. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39954701 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hamer+MJ%22">Hamer MJ</searchLink>; Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA; Department of Emergency Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22McCarty+JM%22">McCarty JM</searchLink>; Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pierson+BC%22">Pierson BC</searchLink>; Division of Medicine, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Regules+JA%22">Regules JA</searchLink>; Division of Medicine, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA; Uniformed Services University (USU) F Edward Hebert School of Medicine, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Mendy+J%22">Mendy J</searchLink>; Bavarian Nordic, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sanborn+AD%22">Sanborn AD</searchLink>; Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA.<br /><searchLink fieldCode="AU" term="%22Gardner+CL%22">Gardner CL</searchLink>; Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Haller+JM%22">Haller JM</searchLink>; Division of Medicine, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Gregory+MK%22">Gregory MK</searchLink>; Division of Medicine, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Liggett+DL%22">Liggett DL</searchLink>; Division of Medicine, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Glass+PJ%22">Glass PJ</searchLink>; Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Ghosh+N%22">Ghosh N</searchLink>; Emergent BioSolutions, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Royalty+Tredo+S%22">Royalty Tredo S</searchLink>; Emergent BioSolutions, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Warfield+KL%22">Warfield KL</searchLink>; Emergent BioSolutions, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Burke+CW%22">Burke CW</searchLink>; Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Lee+C%22">Lee C</searchLink>; Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA.<br /><searchLink fieldCode="AU" term="%22Saunders+D%22">Saunders D</searchLink>; Division of Medicine, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD, USA; Uniformed Services University (USU) F Edward Hebert School of Medicine, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Bedell+L%22">Bedell L</searchLink>; Bavarian Nordic, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Richardson+JS%22">Richardson JS</searchLink>; Bavarian Nordic Canada, Toronto, ON, Canada. Electronic address: JARI@bavarian-nordic.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101769019%22">The Lancet. Microbe</searchLink> [Lancet Microbe] 2025 Apr; Vol. 6 (4), pp. 101000. <i>Date of Electronic Publication: </i>2025 Feb 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101769019 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-5247 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226665247%22">26665247 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Microbe <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39954701 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.lanmic.2024.101000 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101000 Titles: – TitleFull: Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hamer MJ – PersonEntity: Name: NameFull: McCarty JM – PersonEntity: Name: NameFull: Pierson BC – PersonEntity: Name: NameFull: Regules JA – PersonEntity: Name: NameFull: Mendy J – PersonEntity: Name: NameFull: Sanborn AD – PersonEntity: Name: NameFull: Gardner CL – PersonEntity: Name: NameFull: Haller JM – PersonEntity: Name: NameFull: Gregory MK – PersonEntity: Name: NameFull: Liggett DL – PersonEntity: Name: NameFull: Glass PJ – PersonEntity: Name: NameFull: Ghosh N – PersonEntity: Name: NameFull: Royalty Tredo S – PersonEntity: Name: NameFull: Warfield KL – PersonEntity: Name: NameFull: Burke CW – PersonEntity: Name: NameFull: Lee C – PersonEntity: Name: NameFull: Saunders D – PersonEntity: Name: NameFull: Bedell L – PersonEntity: Name: NameFull: Richardson JS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2025 Apr Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2666-5247 Numbering: – Type: volume Value: 6 – Type: issue Value: 4 Titles: – TitleFull: The Lancet. Microbe Type: main |
| ResultId | 1 |